Regulatory Affairs

AHRA Advocacy

About AHRA Regulatory Affairs

The role of the AHRA Regulatory Affairs Committee is to help our members understand, navigate and implement new or changing regulations that affect our industry and specifically, the medical imaging community. Consistent with the goals of AHRA's Strategic Plan, through participation and interaction with a variety of influential national organizations and alliances, we endeavor to expand awareness of AHRA's presence and participation within the healthcare space as an important and influential industry leader.

The mission of AHRA's Regulatory Affairs Committee is to use a systematic approach to evaluate proposed legislation, regulations and budget rules that impact medical imaging. The Committee may also evaluate alliances, partnerships, or coalitions. Existing arrangements will be evaluated annually to ensure that partnerships, alliances, or coalitions further the goals of the organizations stated in the Strategic Plan. All alliances, partnerships or coalitions must include activities to promote the goals of the AHRA. Have a regulatory question? Ask your fellow AHRA Members in the Regulatory and Reimbursement community in Connect!

Health Policy Newsletter

OIG Releases Report Displaying Shortcomings of HIPAA Audits

The Office of Inspector General (OIG) conducted an audit of the Office of Civil Rights’ (OCR) HIPAA audit program to assess how effective the program has been in protecting electronic protected health information (ePHI). The program is designed to ensure compliance with HIPAA Security Rule across HIPAA-covered entities and business associates.

Read More

Previous Newsletters

Latest News

HHS Finalizes Sweeping Non-Discrimination Rule

The Department of Health and Human Services (HHS), through the Office of Civil Rights (OCR) recently released a final rule regarding section... Read More

Official Communications & Comment Letters

2024 IPPS Proposed Rule

2024 OPPS Comments

2024 PFS Comments

View More